Literature DB >> 28500749

Local resectability assessment of head and neck cancer: Positron emission tomography/MRI versus positron emission tomography/CT.

Tetsuro Sekine1,2, Felipe de Galiza Barbosa1, Gaspar Delso1,3, Irene A Burger1, Paul Stolzmann1, Edwin E Ter Voert1, Gerhard F Huber4, Spyros S Kollias5, Gustav K von Schulthess1, Patrick Veit-Haibach1,6, Martin W Huellner1.   

Abstract

BACKGROUND: The purpose of this study was to compare the diagnostic accuracy of positron emission tomography (PET)/MRI with PET/CT for local resectability of head and neck cancer.
METHODS: Sequential contrast-enhanced PET/CT-MRI was performed in 58 patients referred for the staging or restaging of head and neck cancer. Tumors were assessed with PET/CT and PET/MRI for the presence of resectability-defining factors: T4b status (mediastinal invasion, invasion of the prevertebral space, and vascular encasement), and another 8 findings that would imply obstacles for surgical cure (invasion of the laryngeal cartilage, invasion of the preepiglottic fat pad, perineural spread, orbital invasion, bone infiltration, skull base invasion, dural infiltration, and invasion of the brachial plexus).
RESULTS: The sensitivity/specificity/accuracy of local resectability-defining factors of PET/CT and PET/MRI was 0.92/0.99/0.98 and 0.98/0.99/0.99 (P = .727), respectively, per lesion, and 0.96/0.87/0.91 and 0.96/0.90/0.93 (P = .687), respectively, per patient.
CONCLUSION: Both contrast-enhanced PET/MRI and contrast-enhanced PET/CT can serve as reliable examinations for defining local resectability of head and neck cancer.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  ear, nose, and throat (ENT) surgery; head and neck cancer; multimodality imaging; oncology; positron emission tomography (PET)/CT; positron emission tomography (PET)/MRI

Mesh:

Substances:

Year:  2017        PMID: 28500749     DOI: 10.1002/hed.24783

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  4 in total

1.  Current concepts in advanced sinonasal mucosal melanoma: a single institution experience.

Authors:  Christian M Meerwein; Martin Hüllner; Ralph Braun; Michael B Soyka; Grégoire B Morand; David Holzmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-16       Impact factor: 2.503

Review 2.  Magnetic resonance imaging-guided and targeted theranostics of colorectal cancer.

Authors:  Yanan Li; Jingqi Xin; Yongbing Sun; Tao Han; Hui Zhang; Feifei An
Journal:  Cancer Biol Med       Date:  2020-05-15       Impact factor: 4.248

3.  Value of SUVmax for the Prediction of Bone Invasion in Oral Squamous Cell Carcinoma.

Authors:  Stephanie A Stalder; Paul Schumann; Martin Lanzer; Martin W Hüllner; Niels J Rupp; Martina A Broglie; Grégoire B Morand
Journal:  Biology (Basel)       Date:  2020-02-02

4.  FDG-PET predicts bone invasion and prognosis in patients with oral squamous cell carcinoma.

Authors:  Nan-Chin Lin; I-Hsien Su; Jui-Ting Hsu; Kuo-Yang Tsai; Michael Y C Chen
Journal:  Sci Rep       Date:  2021-07-26       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.